Easy-to-use test that provides results in 15 minutes is now available without a prescription The Sofia® SARS Antigen FIA shows excellent performance within the first five days of the onset of symptoms ...
SAN DIEGO--(BUSINESS WIRE)-- Quidel Corporation (NASDAQ: QDEL) (“Quidel”), a provider of rapid diagnostic testing solutions, cellular-based virology assays and molecular diagnostic systems, announced ...
Summer is time for camp—but it's also prime season for Lyme disease. That's the reminder from diagnostic maker Quidel, which has launched an awareness campaign highlighting the rise and risk of the ...
Add Yahoo as a preferred source to see more of our stories on Google. (Reuters) - The U.S. Food and Drug Administration (FDA) on Saturday approved emergency use authorization (EUA) to Quidel Corp ...
While traveling in Florida last March, Quidel Corp. Chief Executive Douglas Bryant received a call from former Vice President Mike Pence’s office asking if he could fly the next day to Washington, D.C ...
Shares of Quidel Corp. surged 32 percent on Monday after the San Diego company received federal approval for a new type of fast, inexpensive COVID-19 test that could help expand coronavirus detection ...
Every battlefront in the fight against COVID-19 is important. Novavax (NVAX +1.45%) is focused on developing a vaccine candidate that could potentially prevent infection by the novel coronavirus.
SAN DIEGO--(BUSINESS WIRE)--Quidel Corporation (NASDAQ: QDEL) (“Quidel”), a leading provider of rapid diagnostic testing solutions, cellular-based virology assays and molecular diagnostic systems, ...
Broadscale application of our Sofia® rapid antigen test for COVID-19 screening will catch asymptomatic cases early and limit virus spread.” The Sofia® SARS Antigen FIA is only for use under the Food ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results